Pharmaceutical Technology Europe-02-01-2009

January was another very bleak month financially, but luckily it ended on a bit of a political high...

Pfizer is no normal company. As recently as 2007 it was still the industry's largest player with $47.5 billion (36.8 billion euro) coming in from pharma sales alone.

Ask the Expert looks at logistic problems.

During the past years, there has been increasing demand for fast dissolving disintegrating tablets (FDDTs), such as orally disintegrating tablets (ODTs) and sublinguals.

A discussion of the basic principles of immunity and the nature of antibodies.

The European dose CMO sector appears to be very vibrant, probably more so than the market in the US.

During the last 20 years, pharmaceutical R&D spending has increased 15-fold while new product approvals have increased only 0.70-fold.